|
ZXDA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.205920E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18369999860357E-09 |
| Normal-vs-Stage2 |
3.629000E-01 |
| Normal-vs-Stage3 |
6.992000E-01 |
| Normal-vs-Stage4 |
6.106600E-01 |
| Stage1-vs-Stage2 |
1.295810E-02 |
| Stage1-vs-Stage3 |
4.13060000000742E-05 |
| Stage1-vs-Stage4 |
8.83090000014519E-07 |
| Stage2-vs-Stage3 |
5.785600E-01 |
| Stage2-vs-Stage4 |
2.451000E-01 |
| Stage3-vs-Stage4 |
4.721800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.16369999999478E-05 |
| Normal-vs-AfricanAmerican |
7.292200E-01 |
| Normal-vs-Asian |
3.179000E-01 |
| Caucasian-vs-AfricanAmerican |
9.480200E-02 |
| Caucasian-vs-Asian |
4.689000E-01 |
| AfricanAmerican-vs-Asian |
1.860200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.102800E-03 |
| Normal-vs-Female |
1.978750E-04 |
| Male-vs-Female |
2.054000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.234400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.59299999999263E-05 |
| Normal-vs-Age(61-80Yrs) |
7.704300E-03 |
| Normal-vs-Age(81-100Yrs) |
6.439200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.938050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.661800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.145000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.496560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.738400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.843600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.758700E-04 |
| Normal-vs-Grade 2 |
3.31650000018335E-07 |
| Normal-vs-Grade 3 |
6.338800E-03 |
| Normal-vs-Grade 4 |
1.223610E-02 |
| Grade 1-vs-Grade 2 |
9.336400E-02 |
| Grade 1-vs-Grade 3 |
1.516430E-02 |
| Grade 1-vs-Grade 4 |
2.94100000020059E-07 |
| Grade 2-vs-Grade 3 |
4.646000E-02 |
| Grade 2-vs-Grade 4 |
1.39099998186509E-09 |
| Grade 3-vs-Grade 4 |
1.78486999999894E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.20348175869367E-12 |
| Normal-vs-ccB subtype |
6.845800E-01 |
| ccA subtype-vs-ccB subtype |
5.78559999908634E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.483670E-03 |
| Normal-vs-N1 |
2.339400E-01 |
| N0-vs-N1 |
3.330100E-02 |
|
|
